SIX Swiss Exchange · Healthcare
Invest in Roche stock from India
Indian and foreign residents can buy Roche (ROP) shares directly through Paasa.
By Paasa · Updated
Roche at a glance
- Price
- CHF 401.80+CHF 0.70 (0.17%)
- Market cap
- CHF 277.27B
- Day range
- CHF 398.80 – CHF 402.60
- P/E
- 26.16
- Dividend yield
- 2.44%
- Volume
- 793.16K
- 1 month
- +12.30%
- 6 months
- +27.43%
- YTD
- +22.43%
- 1 year
- +44.07%
- 5 years
- +8.49%
Roche statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 61.5B | CHF 62.4B | CHF 60.4B | CHF 65.8B | CHF 62.8B |
| Gross profit | CHF 45.2B | CHF 46.1B | CHF 44.1B | CHF 47.9B | CHF 43.1B |
| Operating income | CHF 19.3B | CHF 13.4B | CHF 15.4B | CHF 17.5B | CHF 18.2B |
| Net income | CHF 12.9B | CHF 8.3B | CHF 11.5B | CHF 12.4B | CHF 13.9B |
| Earnings per share | CHF 16.18 | CHF 10.36 | CHF 14.39 | CHF 15.53 | CHF 16.39 |
| EBITDA | CHF 22.6B | CHF 16.6B | CHF 18.4B | CHF 20.8B | CHF 22.2B |
| Total assets | CHF 100.7B | CHF 101.8B | CHF 90.5B | CHF 88.2B | CHF 92.3B |
| Total debt | CHF 33.2B | CHF 36.4B | CHF 30.8B | CHF 26.5B | CHF 32.6B |
| Cash and short-term investments | CHF 15.5B | CHF 17.3B | CHF 10.5B | CHF 9.8B | CHF 13.0B |
| Shareholders' equity | CHF 33.8B | CHF 31.8B | CHF 29.3B | CHF 28.0B | CHF 24.5B |
| Operating cash flow | CHF 17.8B | CHF 20.1B | CHF 16.1B | CHF 17.9B | CHF 20.6B |
| Free cash flow | CHF 14.1B | CHF 15.1B | CHF 11.4B | CHF 13.3B | CHF 16.0B |
| Capital expenditure | −CHF 3.7B | −CHF 5.0B | −CHF 4.6B | −CHF 4.6B | −CHF 4.5B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Eli Lilly | LLY.SW | CHF 1,170.00 | CHF 1.04T |
| Johnson & Johnson | JNJ.SW | CHF 222.05 | CHF 535.12B |
| AbbVie | ABBV | $293.30 | $518.30B |
| Merck | MRK | $148.71 | $366.89B |
| Novartis | NOVN.SW | CHF 134.14 | CHF 253.34B |
| Amgen | AMGN | $465.23 | $251.52B |
| AstraZeneca | AZN.L | £140.74 | £218.28B |
| Gilead Sciences | GILD | $169.32 | $210.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 3 buy · 5 hold · 1 sell. Consensus: Hold.
Published sell-side 12-month targets in CHF, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Roche from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search ROP and buy
Find Roche by name or by its ticker, ROP, and place your order.
Why invest in Roche from India
What Roche does
Roche Holding AG is a prominent global entity primarily active in the pharmaceutical and diagnostics industries. Its extensive operations encompass numerous countries, including key markets such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium, alongside a broader international presence. Roche operates in the Drug Manufacturers - General industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Roche stock from India?
Yes. Indian residents and NRIs can buy Roche (ROP) shares directly through Paasa. Roche is listed on the SIX Swiss Exchange, in the Drug Manufacturers - General industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Roche shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.